SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-046775
Filing Date
2017-07-31
Accepted
2017-07-31 17:57:12
Documents
2
Period of Report
2017-07-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2975
2 EX-24 DOCUMENT attachment1.htm EX-24 1718
  Complete submission text file 0001209191-17-046775.txt   6015
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2855 SAND HILL ROAD MENLO PARK CA 94025
Business Address
Makhzoumi Mohamad (Reporting) CIK: 0001630226 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35670 | Film No.: 17994110